Implementation of clinical next-generation sequencing (NGS) of non-small cell lung cancer (NSCLC) to identify EGFR amplification as a potentially targetable oncogenic alteration.

Authors

Geoffrey Oxnard

Geoffrey R. Oxnard

Dana-Farber Cancer Institute, Boston, MA

Geoffrey R. Oxnard , Christine A. Lydon , Neal Ian Lindeman , Priyanka R. Shivdasani , Gary Y. Chin , Frank C. Kuo , Bruce E. Johnson , Pasi A. Janne , Lynette M. Sholl

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer - Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 8090)

DOI

10.1200/jco.2014.32.15_suppl.8090

Abstract #

8090

Poster Bd #

271

Abstract Disclosures

Similar Posters

Poster

2018 ASCO Annual Meeting

Upfront next generation sequencing in NSCLC: A publicly funded perspective.

Upfront next generation sequencing in NSCLC: A publicly funded perspective.

First Author: Kirstin Perdrizet

Poster

2013 ASCO Annual Meeting

Multiplexed genetic analysis of malignant pleural mesothelioma and the relationship to clinical outcome.

Multiplexed genetic analysis of malignant pleural mesothelioma and the relationship to clinical outcome.

First Author: Takehito Shukuya

Poster

2022 ASCO Annual Meeting

Molecular characterization of NF1-mutated NSCLC and clinical outcomes.

Molecular characterization of NF1-mutated NSCLC and clinical outcomes.

First Author: Christopher Gates